Center-Authored Papers

Filters: Author is De Marzo, Angelo M  [Clear All Filters]
Journal Article
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng LS, Thompson IM et al..  2017.  Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.. The Prostate. Abstract
Gurel B, Lucia SM, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S et al..  2014.  Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Hubbard GK, Mutton LN, Khalili M, McMullin RP, Hicks JL, Bianchi-Frias D, Horn LA, Kulac I, Moubarek MS, Nelson PS et al..  2016.  Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.. Cancer research. 76(2):283-92. Abstract
Tsai H, Morais CL, Alshalalfa M, Tan H-L, Haddad Z, Hicks JL, Gupta N, Epstein JI, Netto GJ, Isaacs WB et al..  2015.  Cyclin D1 Loss Distinguishes Prostatic Small Cell Carcinoma from Most Prostatic Adenocarcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL et al..  2008.  Human Proteinpedia enables sharing of human protein data.. Nature biotechnology. 26(2):164-7.
Murtola T, Gurel B, Umbehr M, Lucia SM, Thompson IM, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S et al..  2015.  Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Platz EA, Sutcliffe S, De Marzo AM, Drake CG, Rifai N, Hsing AW, Hoque A, Neuhouser ML, Goodman PJ, Kristal AR.  2010.  Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.. Cancer causes & control : CCC. 21(6):847-51. Abstract
Guedes L, Antonarakis ES, Schweizer MT, Mirkheshti N, Almutairi F, Park JC, Glavaris SA, Hicks JL, Eisenberger MA, De Marzo AM et al..  2017.  MSH2 Loss in Primary Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Zhu Y, Sharp A, Anderson CM, Silberstein JL, Taylor M, Lu C, Zhao P, De Marzo AM, Antonarakis ES, Wang M et al..  2017.  Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer.. European urology. Abstract
Yu S-H, Zheng Q, Esopi D, Macgregor-Das A, Luo J, Antonarakis ES, Drake CG, Vessella R, Morrissey C, De Marzo AM et al..  2015.  A Paracrine Role for IL-6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.. Cancer immunology research. Abstract
Kulac I, Gumuskaya B, Drake CG, Gonzalez B, Arnold KB, Goodman PJ, Kristal AR, Lucia SM, Thompson IM, Isaacs WB et al..  2016.  Peripheral zone inflammation is not strongly associated with lower urinary tract symptom incidence and progression in the placebo arm of the prostate cancer prevention trial .. The Prostate. Abstract
Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia SM, Klein EA, Lippman SM, Parnes HL et al..  2017.  A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Sutcliffe S, Till C, Jenkins FJ, Gaydos CA, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Nelson WG, De Marzo AM et al..  2015.  Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.. Cancer causes & control : CCC. 26(1):35-44. Abstract
Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia SM, Goodman PJ, Lippman SM, Thompson IM, Platz EA et al..  2015.  Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.. The Prostate. 75(11):1160-6. Abstract
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng LS, Thompson IM et al..  2015.  Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.. The Prostate. Abstract